Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
Clinical trial NCT04335071 · TERMINATED
Trial details
- NCT number
- NCT04335071
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-26
- Primary completion
- 2020-09-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.